|
CCDC150 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.483400E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.151200E-01 |
| Normal-vs-Stage2 |
1.595980E-03 |
| Normal-vs-Stage3 |
5.639600E-01 |
| Normal-vs-Stage4 |
3.554600E-01 |
| Stage1-vs-Stage2 |
1.365510E-04 |
| Stage1-vs-Stage3 |
7.253800E-01 |
| Stage1-vs-Stage4 |
8.466000E-02 |
| Stage2-vs-Stage3 |
1.244910E-03 |
| Stage2-vs-Stage4 |
8.828100E-04 |
| Stage3-vs-Stage4 |
1.498230E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.675800E-01 |
| Normal-vs-AfricanAmerican |
2.036800E-01 |
| Normal-vs-Asian |
9.429800E-01 |
| Caucasian-vs-AfricanAmerican |
2.466200E-01 |
| Caucasian-vs-Asian |
6.178200E-01 |
| AfricanAmerican-vs-Asian |
1.647360E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.087600E-01 |
| Normal-vs-Female |
1.689210E-01 |
| Male-vs-Female |
5.938000E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.022800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.900200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.349200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.440000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.534100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.241200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.703200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.478370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.448600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.864400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.021000E-01 |
| Classical-VS-Follicular |
1.396660E-04 |
| Classical-VS-Other |
9.667200E-01 |
| Classical-VS-Normal |
8.190400E-01 |
| Tall-VS-Follicular |
8.319500E-03 |
| Tall-VS-Other |
9.218800E-01 |
| Tall-VS-Normal |
9.556600E-01 |
| Follicular-VS-Other |
1.743240E-01 |
| Follicular-VS-Normal |
5.679600E-03 |
| Other-VS-Normal |
9.591400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.563550E-01 |
| Normal-vs-N1 |
4.604000E-01 |
| N0-vs-N1 |
5.292300E-02 |
|
|
